Angiotensin-converting-enzyme inhibitors in the treatment of hypertension
Coats, A.J.
British Journal of Hospital Medicine 38(6): 531
1987
ISSN/ISBN: 0007-1064 PMID: 2829986 Document Number: 292069
Angiotensin-converting-enzyme inhibitors have become an important element in the antihypertensive armamentarium. They are well tolerated and efficacious in essential and secondary hypertension, and may open new insights into the pathophysiology of the hypertensive state.
Document emailed within 1 workday
Related Documents
Mancia, G. 1991: Angiotensin-converting enzyme inhibitors in the treatment of hypertension Journal of Cardiovascular Pharmacology 18(Suppl 7): S1-S3Materson, B.J. 1983: Angiotensin converting enzyme inhibitors in the treatment of hypertension Comprehensive Therapy 9(10): 14-20
Salvetti, A.; Pedrinelli, R.; Abdel-Haq, B.; Magagna, A.; Lucarini, A.; Graziadei, L.; Nuccorini, A.; Taddei, S. 1984: Inhibitors of angiotensin-converting enzyme in the treatment of arterial hypertension Cardiologia 29(1-2): 103-120
Babadzhan, V.D. 2000: Angiotensin-converting enzyme inhibitors in the treatment of arterial hypertension Likars'ka Sprava 2: 19-26
Shulman, N.B. 1988: Treatment of hypertension in black patients with angiotensin-converting enzyme inhibitors Journal of the National Medical Association 80(3): 265-272
Januszewicz, A.; Lapiński, M. 1992: Angiotensin converting enzyme inhibitors. Increasing importance in the treatment of hypertension Kardiologia Polska 37(12): 393-397
Materson, B.J.; Preston, R.A. 1994: Angiotensin-converting enzyme inhibitors in hypertension. A dozen years of experience Archives of Internal Medicine 154(5): 513-523
Franca, G.; Cosenzi, A.; Piemontesi, A.; Bellini, G. 1988: Efficacy of angiotensin-converting enzyme inhibitors in the therapy of arterial hypertension in the aged Giornale di Clinica Medica 69(11): 665-669
Szczotka, B.; Jaźwińska-Tarnawska, E.; Wedlarski, R.ł; Łapiński, Łu.; Wiela-Hojeńska, A. 2013: Evaluation of efficacy and safety of hypertension treatment with original angiotensin-converting enzyme inhibitors: the comparison of original and generic formulations Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 34(201): 140-144
González-Juanatey, J.R. 2000: Angiotensin converting enzyme inhibitors in arterial hypertension and cardiac failure. The question of the dose Medicina Clinica 114 Suppl. 2: 24-27
Karlberg, B.E.; Fyhrquist, F.; Grönhagen-Riska, C.; Tikkanen, I.; Ohman, K.P. 1984: Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report Scandinavian Journal of Urology and Nephrology. Supplementum 79: 103-106
Tajima, J.; Abe, K.; Yasujima, M.; Tanno, M.; Yoshinaga, K. 1984: Effects of 3 different angiotensin converting enzyme inhibitors, MK 421, SQ 14225 and SA 446 on renal function and blood pressure in patients with essential hypertension Nihon Jinzo Gakkai Shi 26(6): 779-789
Svarstad, E.; Willassen, Y.; Iversen, B.M. 1992: Severe renal failure during treatment with angiotensin-converting enzyme inhibitors Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 112(4): 463-465
Kolber-Postepska, B. 1992: Treatment of chronic congestive heart failure using angiotensin converting enzyme inhibitors Wiadomosci Lekarskie 45(23-24): 903-906
Ganten, D.; Mullins, J.; Lindpaintner, K. 1989: The tissue renin-angiotensin system: a target for angiotensin-converting enzyme inhibitors Journal of Human Hypertension 3(Suppl 1): 63-70
De Paz, S.; Martín, A.B.; Iglesias, A.; Domínguez, A.R. 1999: Angioedema-urticaria caused by angiotensin-converting enzyme inhibitors and angiotensin Ii receptor antagonists Medicina Clinica 113(19): 759
Ghali, J.K.; Giles, T.; Gonzales, M.; Horswell, R.; Kumar, S.; Lejuene, A.; Livaudais, G.F.; Sarkar, I.C. 1997: Patterns of physician use of angiotensin converting enzyme inhibitors in the inpatient treatment of congestive heart failure Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 149(12): 474-484
Jover, B.; Mimran, A. 1994: Angiotensin II receptor antagonists versus angiotensin converting enzyme inhibitors: effects on renal function Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 12(9): S3-S9
Krzesinski, J.M.; Montrieux, C.; Scheen, A.J. 2006: Angiotensin converting enzyme inhibitors or angiotensin Ii receptor blocker in cardiovascular and renal pathology in 2006: what does EBM teach us? Revue Medicale de Liege 61(5-6): 414-422
Voronkov, L.G.; Serdiuk, T.E.; Riabenko, D.V. 2000: Use of inhibitors of the angiotensin-converting enzyme and the beta-adrenoblocker metoprolol combined in treatment of chronic cardiac insufficiency Likars'ka Sprava 2000(7-8): 77-80